SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-028004
Filing Date
2021-04-22
Accepted
2021-04-22 19:02:36
Documents
2
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2154
2 POA DOCUMENT poa.txt EX-24.3_980506 2887
  Complete submission text file 0001209191-21-028004.txt   6430
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL NEUROPHARMA INC (Issuer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMPEL NEUROPHARMA, INC. 201 ELLIOTT AVE. W, ST. 260 SEATTLE WA 98119
Business Address
Allison David D. (Reporting) CIK: 0001853903 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40353 | Film No.: 21846206